Stocks to sell

I usually avoid the word “bet” when providing financial analysis. That’s because rigorous financial analysis is the opposite of a bet. Rather, it’s a decision supported by solid arguments and facts, all of which form either a bullish or a bearish thesis. But when it comes to sports-betting company DraftKings (NASDAQ:DKNG), I guess I’ll allow

MicroVision (NASDAQ:MVIS) is still up for sale, at least according to the company’s latest 10-Q report. The reason is pretty simple. It still only has one customer for its Lidar products. And that is on a royalty revenue basis. This leaves MVIS stock fairly overvalued at the present time. Source: shutterstock.com/temp-64GTX I have written about

I can understand why people like ContextLogic (NASDAQ:WISH) stock. There are some compelling reasons why you’d want to root for this underdog. Source: sdx15 / Shutterstock.com Unfortunately, there aren’t enough of those reasons based in fact to make WISH stock a very compelling investment. So, as much as it would be fun to put your

The current situation in clean energy stocks reminds several analysts of the dot-com boom in the late 1990s. According to data from Morningstar, global inflows into clean energy exchange-traded funds (ETFs) jumped to $14.7 billion in the six months to the end of March, up from only $1.3 billion in the same period a year

Tesla (NASDAQ:TSLA) created the electric car market, starting with the luxury end and working down. Source: Sheila Fitzgerald / Shutterstock.com This has made CEO Elon Musk a centi-billionaire. TSLA stock was worth $741 billion as trading began September 22. The company was only marginally profitable until its June quarter report showed it bringing nearly $1

Restaurant stocks have had a challenging couple of years now. The U.S. economy was almost on full throttle earlier this year, nearly hitting escape velocity from the pandemic. But things turned around as the year progressed. Now we sit on variety of conflicting economic indicators — some encouraging, other flashing warning signs. And so, while

Sesen Bio (NASDAQ:SESN) is a small biotech company attempting to develop a drug it calls Vicineum. SESN stock plunged last month after hitting a massive regulatory setback. Source: luchschenF / Shutterstock.com Sesen’s Vicineum aims to treat unresponsive non-muscle invasive bladder cancer using a locally administered recombinant fusion protein method. However, the Food and Drug Administration

When I wrote about Nio (NYSE:NIO) last month, I argued that the risks that could send NIO stock lower outweighed factors that could help it bounce back. Source: Robert Way / Shutterstock.com The Chinese electric vehicle (EV) maker has numerous strengths, such as high projected rates of growth in its home market. It also has

Peloton Interactive (NASDAQ:PTON) is wildly overvalued at its present valuation of $30.3 billion. A major reason is that the company’s latest quarter showed a massive loss in free cash flow. This adds up to a cash crunch for Peloton sometime in the near future if this trend continues. And that is not going to fare

Aterian (NASDAQ:ATER) is a consumer products platform that, according to Yahoo! Finance, uses software which implements “machine learning, natural language processing, and data analytics to design, develop, market, and sell products.” Essentially, Aterian scales consumer brands. But what should you know about ATER stock? Source: Shutterstock This company calls itself a “leading consumer product platform” —

Earlier this month, Alibaba (NYSE:BABA) looked as though it had bottomed. Speculators bet on BABA stock bottoming at $160 by bidding the stock up close to $180, its 50-day simple moving average. Source: BigTunaOnline / Shutterstock.com The rally did not last because traders failed to account for the ongoing political risks and the massive “forced

As one of the most widely followed SPAC offerings this year, Clover Health (NASDAQ:CLOV) has not exactly set the world on fire. After debuting on Jan. 8, the stock has mostly drifted downward with the exception of a short-term trading boost earlier this summer. CLOV stock currently has a $3.4 billion market capitalization and $412

Affirm (NASDAQ:AFRM), the premier “buy now, pay later” (BNPL) lender with various merchants and shopping portals, still isn’t profitable. Buying AFRM stock now is likely to make you pay later since the company is cascading its losses with higher revenue and loans. Source: Piotr Swat / Shutterstock.com But don’t tell that to recent investors in

Vinco Ventures (NASDAQ:BBIG) stock is the latest meme play. But if you blink, you might miss it. Source: Michael Vi via Shutterstock Vinco is an investment company that has gotten into non fungible tokens (NFTs), launching an E-NFT platform for trading them. It also owns 80% of a short video content platform (think TikTok) called

Driven by a few factors, the outlook of DraftKings (NASDAQ:DKNG) stock has definitely improved. Source: Tada Images / Shutterstock.com Nonetheless, I’m still worried about the company’s bottom line, and I think that the stock’s current valuation likely reflects the company’s long-term potential. One factor that has made DKNG stock a better bet is the declining

AT&T (NYSE:T) participated in the Bank of America (BofA) Communications and Entertainment Conference on Sept. 14. The CFO, Pascal Desroches, shed more light on its upcoming WarnerMedia combination with Discovery Inc (NASDAQ:DISCA). He also discussed the resulting expected dividend cut. Since then, T stock has kept falling. Source: Jonathan Weiss / Shutterstock.com So far this

Investors pay up for growth. Witness Pinterest (NYSE:PINS). Revenues grew 48% in 2020. They rose 26% between the first and second quarter 2021. They should easily exceed the 2020 total after Q3 numbers are announced on Oct. 28. If 2021 sales hit $2.246 billion, the current PINS stock price equates to about 15 times sales. Source:

For years, many analysts considered Alibaba (NYSE:BABA) stock to be a no-brainer investment on the mercurial growth of the Chinese economy, particularly its burgeoning technology sector. Source: BigTunaOnline / Shutterstock.com For the most part, they’ve been right, with BABA stock soaring following some rough outings post its initial public offering. Today, the circumstances have completely

Reddit traders recently tried to send Clover Health (NASDAQ:CLOV) stock “to the moon” once again. Source: Shutterstock The stock managed to crack $10 per share, but ultimately this rocket l did not launch. Instead of sending it back to the $25+ it traded for in June (during its short-squeeze rally), shares in the Medicare Advantage

The continued automobile scarcity in the U.S. continued in August, according to J.D. Power. Investors may react to the auto shortage by buying car companies dependent on internal combustion engines. Watching the electric vehicle market unfold is a better growth opportunity. Lucid Group (NASDAQ:LCID) is an especially compelling trade, with LCID stock stuck in a narrow